Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4
Jan 14. [Epub ahead of print]
Ford ML, Tomlinson LA, Smith ER et al. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant 2010; Jan 14. [Epub ahead of print]
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function
Roos M, Lutz J, Salmhofer H et al. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol 2008; 68: 660-665
Fetuin-A and kidney function in persons with coronary artery disease: Data from the Heart and Soul Study
Ix JH, Chertow GM, Shlipak MG et al. Fetuin-A and kidney function in persons with coronary artery disease: data from the Heart and Soul Study. Nephrol Dial Transplant 2006; 21: 2144-2151
The serum protein alpha 2- Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
Schafer C, Heiss A, Schwarz A et al. The serum protein alpha 2- Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease data from the heart and soul study
Ix JH, Chertow GM, Shlipak MG et al. Association of fetuin-a with mitral annular calcification and aortic stenosis among persons with coronary heart disease data from the heart and soul study. Circulation 2007; 115: 2533-2539
Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class
Davutoglu V, Celik A, Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis 2006; 14: 251-256